- Anti‐D administration after childbirth for preventing Rhesus alloimmunisation
- Anti‐D administration in pregnancy for preventing Rhesus alloimmunisation
- Antidepressant treatment for postnatal depression
- Antidepressants for preventing postnatal depression
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
- Antioxidants for preventing pre-eclampsia
- Antiplatelet agents for preventing pre‐eclampsia and its complications
- Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum
- Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women
- Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection
- Antispasmodics for labour
- Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction
- Aromatherapy for pain management in labour
- Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia
- Aspirin for in vitro fertilisation
- Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI))
- Assisted reproductive technologies for male subfertility
- Bed rest during pregnancy for preventing miscarriage
- Bed rest in hospital for suspected impaired fetal growth
- Bed rest in singleton pregnancies for preventing preterm birth
The Cochrane Database of Systematic Reviews is considered the gold standard for evidence-based medicine. Essential Evidence Plus includes the latest and most up-to-date summaries of systematic reviews from the Cochrane Library, which are the most rigorous and reliable evaluations of medical therapies available. You’ll find summarized evaluations of the world’s best literature on the effectiveness of therapy for 3,300+ clinical problems.
